Skip to content

About Tattva

UPSC doesn't require you to know everything in the news. It requires you to understand what matters.

Tattva turns daily current affairs into structured, exam-oriented knowledge for UPSC and competitive-exam aspirants.

The North and South Block secretariat buildings in New Delhi, reflected in the pool below them

Relevance over volume

Analysis over summary

Recall over memorizing

Structured, not scattered

Built for the UPSC syllabus

The aspirant's morning

  • Read the newspaper
  • Highlight articles
  • Save links
  • Look up the background
  • Make notes

After all of it, one question is still there:

What should I actually remember for UPSC?

The insight

The problem isn't a lack of information. It's the lack of structure around information.

You don't have an information problem. You have a relevance and learning problem.

What Tattva does

From the news to something you can learn from

  1. News

    The day's stories, as the sources published them.

  2. Filter

    Only what's relevant to the syllabus.

  3. Context

    The bigger issue it belongs to.

  4. Analysis

    What happened, why it matters, who gains and loses.

  5. UPSC connection

    The GS papers it maps to.

  6. PYQs

    Real past questions, where a genuine match exists.

  7. Thinking

    The questions it leaves you with.

One real story

11 articles. One story you can learn from.

From pharmacy to laboratory: India's leap into drug discovery · India Today · 3 October 2026

Before

11 articles about the same story

With Tattva

One structured story

Background
India’s pharmaceutical sector is the world’s third‑largest by volume, with more than 3,000 companies and 10,500 manufacturing units, yet it is only the 11th by value, reflecting a dominance of low‑margin generics.
Syllabus
  • GS III
  • Prelims GS I
  • Essay
  • GS II
PYQs
  • GS III · 2020 Discuss the challenges and opportunities faced by the Indian pharmaceutical industry in moving from generic drug manufacturing to novel drug discovery.
  • GS III · 2022 Examine the role of artificial intelligence in enhancing research and development in biotechnology.
Concepts
  • Biopharma Shakti Mission
  • CRDMO
  • AI-driven drug discovery
  • Viksit Bharat@2047
Questions
  • Funding allocation vs. fiscal prudence
  • Regulatory speed vs. safety and efficacy assurance
  • Start‑up promotion vs. incumbent generic industry stability
  • AI investment vs. wet‑lab infrastructure development

A real story from the 3 October 2026 edition. The numbers are the pipeline's own.

The people

Why we built Tattva.

Why we built Tattva: a few lines from the founders, in their own words.

Where this goes

A generation of aspirants who don't just consume current affairs, but learn to think through them.

Make current affairs work for your UPSC preparation.

Stop spending your study time figuring out what matters. See what's worth knowing. Understand why it matters. Learn what to take forward.